Patients with Spondyloarthritis and obesity who fail TNF antagonist therapy: Change the subcutaneous injection site before the biologic? Comment on: "Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: A systematic review and meta-analysis" by Shan et al. Joint Bone Spine, 2019, 86, 173-183

Joint Bone Spine. 2020 Jan;87(1):103-104. doi: 10.1016/j.jbspin.2019.09.003. Epub 2019 Sep 11.
No abstract available

Keywords: Obesity; Spondyloarthritis; TNF antagonist.

Publication types

  • Letter
  • Comment

MeSH terms

  • Biological Factors
  • Biological Products*
  • Humans
  • Injections, Subcutaneous
  • Obesity
  • Spondylarthritis*

Substances

  • Biological Factors
  • Biological Products